Improving the Economic Burden of Ankylosing Spondylitis: Targeting IL-17/IL-23 Pathways

The tablet formulation of zanubrutinib (Brukinsa; BeOne) is now approved for all 5 indications across several hematological cancers.

Julia Lucaci, PharmD, MS, of Becton, Dickinson and Company, discusses the benefits of blister packaging for chronic medications, advocating for payer incentives to boost medication adherence and improve health outcomes.

Race-free kidney function equations may underestimate risks for Black adults according to a new analysis.

A quick roundup episode of major health policy developments, from shifting COVID-19 vaccine guidance and scientific publishing controversies to rising cancer care costs and the impact of oncology biosimilars.

Mansi Shah, MD, discusses the role of stem cell transplant in multiple myeloma (MM) and the logistical barriers to wider adoption of bispecific therapies.

Those who developed primary open-angle glaucoma (POAG) had lower mental health scores compared with those who had not developed the condition.